No results for ‘’
Valiant Laboratories Ltd
₹67.90
(1.21%)
Wed, 24 Jun 2026, 01:43 pm
Health Technology
Pharmaceuticals: Major
24.5KValiant Laboratories Debt to Equity Ratio
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 1730 | 0 |
| Price to book ratio | 0 | 0 | 0 | 2.67 | 1.42 |
| Price to sales ratio | 0 | 0 | 0 | 3.04 | 2.50 |
| Price to cash flow ratio | 0 | 0 | 0 | 306.13 | 254 |
| Enterprise value | 0 | 0 | 0 | 486Cr | 379Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.01 | 0.86 | 0.60 | 0.32 | 0.52 |
| Return on equity % | 0 | 34.36 | 33.73 | 0.19 | -0.93 |
Valiant Laboratories Ltd Debt to Equity Ratio
The Valiant Laboratories Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Valiant Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Valiant Laboratories Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Valiant Laboratories Ltd (NSE: VALIANTLAB, BSE: 543998) is currently trading at ₹67.90, with a market capitalization of ₹374.65Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Valiant Laboratories Ltd Debt to Equity Ratio is essential for fundamental analysis.
Valiant Laboratories Ltd Debt to Equity Ratio Current Value
The current Valiant Laboratories Ltd Debt to Equity Ratio stands at 0.52.
The latest Valiant Laboratories Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Valiant Laboratories Ltd Debt to Equity Ratio Historical Trend
The Valiant Laboratories Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.52
- 2023: 0.32
- 2022: 0.60
- 2021: 0.86
- 2020: 0.01
The recent rise in Valiant Laboratories Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Valiant Laboratories Ltd Debt to Equity Ratio Indicates for Investors
The Valiant Laboratories Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Valiant Laboratories Ltd Debt to Equity Ratio Analysis Summary
The Valiant Laboratories Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Valiant Laboratories Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Valiant Laboratories Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.